Haw Par Limited 

$8.05
+$0.55+7.33% Monday 20:00

統計

當日最高
7.5
當日最低
7.5
52週最高
8.05
52週最低
7.03
成交量
1,050
平均成交量
10
市值
1.72B
市盈率
9.47
股息收益率
3.75%
股息
0.3

即將到來

股息

3.75%股息收益率
10年增長
6.58%
5年增長率
6.67%
3年增長率
10.54%
1年增長率
15.94%

收益

30Jun預期
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
0
0.05
0.1
0.15
預期每股收益
0
實際每股收益
0.0889

人們還關注

此列表基於在 Stock Events 上關注 HAWPF 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Pharmaceuticals: Generic
Health Technology
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.
Show more...
首席執行官
國家
SG
ISIN
SG1D25001158

上市公司